Published in Am J Cardiol on April 07, 2006
Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI2D) | NCT00006305
A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C. Clin Gastroenterol Hepatol (2011) 3.11
Predictors of response of US veterans to treatment for the hepatitis C virus. Hepatology (2007) 2.89
Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome. Ann Intern Med (2014) 2.69
Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Am J Cardiol (2006) 2.25
Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve. Circulation (2013) 2.13
Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. Circulation (2004) 1.73
Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study. Ann Intern Med (2013) 1.69
Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease. Am J Med (2003) 1.63
Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. Circulation (2010) 1.56
The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease. A collaborative analysis of individual patient data from 10 randomized trials. J Am Coll Cardiol (2012) 1.46
Modifications of coronary risk factors. Am J Cardiol (2006) 1.41
Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2005) 1.28
National quality forum performance measures for HIV/AIDS care: the Department of Veterans Affairs' experience. Arch Intern Med (2010) 1.24
Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease. Am Heart J (2007) 1.18
Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease. Am Heart J (2007) 1.11
Quality of life and time trade-off utility measures in patients with coronary artery disease. Am Heart J (2003) 1.05
Modeling GFR trajectories in diabetic nephropathy. Am J Physiol Renal Physiol (2005) 0.94
Increasing pre-pregnancy body mass index is predictive of a progressive escalation in adverse pregnancy outcomes. J Matern Fetal Neonatal Med (2012) 0.89
Postmarketing use of enfuvirtide in veterans: provider compliance with criteria for use, overall efficacy, and tolerability. Ann Pharmacother (2008) 0.89
Provider prescribing of 4 antiretroviral agents after implementation of drug use guidelines in the Department of Veterans Affairs. J Manag Care Pharm (2009) 0.87
Economic evaluation in long-term clinical trials. Stat Med (2002) 0.85
The effect of internal thoracic artery grafts on long-term clinical outcomes after coronary bypass surgery. J Thorac Cardiovasc Surg (2011) 0.83
Effect of race on the clinical outcomes in the bypass angioplasty revascularization investigation trial. Circ Cardiovasc Qual Outcomes (2009) 0.81
The impact of change in pregnancy body mass index on cesarean delivery. J Matern Fetal Neonatal Med (2013) 0.81
Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. Circulation (2009) 0.79
Pregnancy outcomes in the super obese, stratified by weight gain above and below institute of medicine guidelines. Obstet Gynecol (2014) 0.79
The impact of change in pregnancy body mass index on macrosomia. Obesity (Silver Spring) (2014) 0.77
Comparative effectiveness of multivessel coronary artery bypass graft surgery and multivessel percutaneous coronary intervention. Ann Intern Med (2013) 0.75
Statement of the problem. Am J Cardiol (2006) 0.75
The year in epidemiology, health services research, and outcomes research. J Am Coll Cardiol (2009) 0.75